mHealth for Pneumonia Prevention
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Pneumonia
Related studies linked through entity extraction aliases.
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
- Status
- COMPLETED
- Phase
- PHASE2
Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients
- Status
- COMPLETED
- Phase
- N/A
Eosinophil-guided Reduction of Inhaled Corticosteroids
- Status
- COMPLETED
- Phase
- PHASE4
Pediatric and Ambulatory Research in Infectious Diseases
- Status
- RECRUITING
- Phase
- N/A
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
- Status
- UNKNOWN
- Phase
- PHASE2
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
- Status
- UNKNOWN
- Phase
- N/A
Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
- Status
- RECRUITING
- Phase
- N/A
Universal Anti-Viral Vaccine for Healthy Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
- Status
- TERMINATED
- Phase
- PHASE2
Respiratory Complications in ALS
- Status
- COMPLETED
- Phase
- N/A
Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia
- Status
- COMPLETED
- Phase
- N/A
Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)
- Status
- WITHDRAWN
- Phase
- PHASE1
Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar
- Status
- COMPLETED
- Phase
- N/A
Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.
- Status
- COMPLETED
- Phase
- N/A
Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19
- Status
- COMPLETED
- Phase
- N/A